These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 24704867

  • 21. [Antisynthetase syndromes].
    Bauhammer J, Fiehn C.
    Z Rheumatol; 2019 Sep; 78(7):645-655. PubMed ID: 31346706
    [Abstract] [Full Text] [Related]

  • 22. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    Preger C, Notarnicola A, Hellström C, Wigren E, Fernandes-Cerqueira C, Kvarnström M, Wahren-Herlenius M, Idborg H, Lundberg IE, Persson H, Gräslund S, Jakobsson PJ.
    J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.
    Patel P, Marinock JM, Ajmeri A, Brent LH.
    Int J Mol Sci; 2024 Apr 18; 25(8):. PubMed ID: 38674039
    [Abstract] [Full Text] [Related]

  • 25. Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.
    Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R.
    J Clin Pathol; 2014 Aug 18; 67(8):678-83. PubMed ID: 24891607
    [Abstract] [Full Text] [Related]

  • 26. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O.
    JAMA Neurol; 2018 Dec 01; 75(12):1528-1537. PubMed ID: 30208379
    [Abstract] [Full Text] [Related]

  • 27. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
    Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O.
    J Rheumatol; 2012 Sep 01; 39(9):1835-9. PubMed ID: 22859355
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
    Phuong TNT, Ngoc LNT, Rönnelid J, Padyukov L, Lundberg IE.
    Int J Rheum Dis; 2021 May 01; 24(5):663-670. PubMed ID: 33788398
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T.
    Autoimmunity; 2006 May 01; 39(3):233-41. PubMed ID: 16769657
    [Abstract] [Full Text] [Related]

  • 32. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
    Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M.
    Arthritis Rheum; 2006 Oct 15; 55(5):791-8. PubMed ID: 17013837
    [Abstract] [Full Text] [Related]

  • 33. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.
    Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Danieli MG, Oakley P, Griger Z, Nguyen Thi Phuong T, Kodishala C, Vazquez-Del Mercado M, Andersson H, De Paepe B, De Bleecker JL, Maurer B, McCann L, Pipitone N, McHugh N, New RP, Ollier WE, Krogh NS, Vencovsky J, Lundberg IE, Chinoy H, MYONET Registry.
    Rheumatology (Oxford); 2024 Aug 01; 63(8):2093-2100. PubMed ID: 37698987
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J.
    Presse Med; 2010 Oct 01; 39(10):1010-25. PubMed ID: 20655695
    [Abstract] [Full Text] [Related]

  • 40. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies.
    Okiyama N, Fujimoto M.
    F1000Res; 2019 Oct 01; 8():. PubMed ID: 31824645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.